In vivo MR evaluation of the effect of the CCR2 antagonist on macrophage migration

Magnetic Resonance in Medicine

Volumn 64, Issue 1, 2010, Pages 72-79

  Lee, Yedaun ^a   Ryu, Je Won ^b   Chang, Hyeujin ^b   Sohn, Jin Young ^b   Lee, Kyung Won ^b   Woo, Chul Ng ^b   Kang, Hee Jung ^c   Jeong, Seong Yun ^b   Choi, Eun Kyung ^a,b   Lee, Jin Seong ^a,b  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Medical Center   (South Korea)

^c Hallym University College of Medicine   (South Korea)

Author keywords

CCR2 antagonist; Cell migration; In vivo MR imaging; Macrophage; Monocyte chemoattractant protein 1

Indexed keywords

BINDING ENERGY; IRON OXIDES; MAGNETIC RESONANCE IMAGING; MAMMALS; PROTEINS; RNA; SUPERPARAMAGNETISM;

CCR2 ANTAGONIST; CELL MIGRATION; CHEMOATTRACTANTS; CHEMOTACTIC ACTIVITY; DIRECTIONAL MIGRATION; MR IMAGING; RECEPTOR ANTAGONISTS; SUPERPARAMAGNETIC IRON OXIDES;

MACROPHAGES;

CD11B ANTIGEN; CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR2; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; RS 102895; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; PIPERIDINE DERIVATIVE; SPIRO COMPOUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BINDING AFFINITY; BINDING ASSAY; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVITY; FEASIBILITY STUDY; GASTROCNEMIUS MUSCLE; IN VIVO STUDY; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; ANTAGONISTS AND INHIBITORS; CELL MOTION; CONFOCAL MICROSCOPY; DOWN REGULATION; DRUG EFFECTS; GENETICS; MACROPHAGE; METABOLISM; RADIOGRAPHY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD11B; CELL MOVEMENT; CHEMOKINE CCL2; DOWN-REGULATION; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MALE; MICE; MICROSCOPY, CONFOCAL; PIPERIDINES; RECEPTORS, CCR2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPIRO COMPOUNDS;

EID: 77953940920     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22409     Document Type: Article

References (28)

1. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996;2:198-204. (Pubitemid 126401890)
2. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242.
3. Mirzadegan T, Diehl F, Ebi B, Bhakta S, Polsky I, McCarley D, Mulkins M, Weatherhead GS, Lapierre JM, Dankwardt J, Morgans D Jr, Wilhelm R, Jarnagin K. Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists: binding to a common chemokine receptor motif within the helical bundle. J Biol Chem 2000;275:25562-25571.
4. Kurihara T, Warr G, Loy J, Bravo R. Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med 1997;186:1757-1762. (Pubitemid 27506288)
5. Nelken NA, Coughlin SR, Gordon D, Wilcox JN. Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-1127.
6. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, Burdick MD, Pope RM, Strieter RM. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992;90:772-779.
7. Stasikowska O, Wagrowska-Danilewicz M. Chemokines and chemokine receptors in glomerulonephritis and renal allograft rejection. Med Sci Monit 2007;13:RA31-36.
8. Flory CM, Jones ML, Warren JS. Pulmonary granuloma formation in the rat is partially dependent on monocyte chemoattractant protein 1. Lab Invest 1993;69:396-404.
9. Lukacs NW, Strieter RM, Warmington K, Lincoln P, Chensue SW, Kunkel SL. Differential recruitment of leukocyte populations and alteration of airway hyperreactivity by C-C family chemokines in allergic airway inflammation. J Immunol 1997;158:4398-4404. (Pubitemid 127483943)
10. Gong JH, Ratkay LG, Waterfield JD, Clark-Lewis I. An antagonist of monocyte chemoattractant protein 1 (MCP-1) inhibits arthritis in the MRL-lpr mouse model. J Exp Med 1997;186:131-137. (Pubitemid 27304855)
11. Metz S, Bonaterra G, Rudelius M, Settles M, Rummeny EJ, Daldrup-Link HE. Capacity of human monocytes to phagocytose approved iron oxide MR contrast agents in vitro. Eur Radiol 2004;14:1851-1858. (Pubitemid 39386634)
12. Daldrup-Link HE, Rudelius M, Piontek G, Metz S, Brauer R, Debus G, Corot C, Schlegel J, Link TM, Peschel C, Rummeny EJ, Oostendorp RA. Migration of iron oxide-labeled human hematopoietic progenitor cells in a mouse model: in vivo monitoring with 1.5-T MR imaging equipment. Radiology 2005;234:197-205.
13. Lee JS, Kang HJ, Gong G, Jung HD, Lim KH, Kim ST, Lim TH. MR imaging of in vivo recruitment of iron oxide-labeled macrophages in experimentally induced soft-tissue infection in mice. Radiology 2006;241:142-148. (Pubitemid 44433344)
14. Lee JS, Sohn JY, Jung HD, Kim ST, Lee KG, Kang HJ. Pace of macrophage recruitment during different stages of soft tissue infection: Semi-quantitative evaluation by in vivo magnetic resonance imaging. Eur Radiol 2008;18:2033-2039.
15. Tangirala RK, Murao K, Quehenberger O. Regulation of expression of the human monocyte chemotactic protein-1 receptor (hCCR2) by cytokines. J Biol Chem 1997;272:8050-8056. (Pubitemid 27137371)
16. Bharadwaj D, Stein MP, Volzer M, Mold C, Du Clos TW. The major receptor for C-reactive protein on leukocytes is fcgamma receptor II. J Exp Med 1999;190:585-590. (Pubitemid 29395386)
17. Power CA, Proudfoot AE. The chemokine system: novel broad-spectrum therapeutic targets. Curr Opin Pharmacol 2001;1:417-424. (Pubitemid 33585993)
18. Brodmerkel CM, Huber R, Covington M, Diamond S, Hall L, Collins R, Leffet L, Gallagher K, Feldman P, Collier P, Stow M, Gu X, Baribaud F, Shin N, Thomas B, Burn T, Hollis G, Yeleswaram S, Solomon K, Friedman S, Wang A, Xue CB, Newton RC, Scherle P, Vaddi K. Discovery and pharmacological characterization of a novel rodent-active CCR2 antagonist, INCB3344. J Immunol 2005;175:5370-5378.
19. Schnitzler N, Haase G, Podbielski A, Lutticken R, Schweizer KG. A co-stimulatory signal through ICAM-beta2 integrin-binding potentiates neutrophil phagocytosis. Nat Med 1999;5:231-235. (Pubitemid 29068533)
20. Brake DK, Smith EO, Mersmann H, Smith CW, Robker RL. ICAM-1 expression in adipose tissue: effects of diet-induced obesity in mice. Am J Physiol Cell Physiol 2006;291:C1232-1239.
21. Piga R, Naito Y, Kokura S, Handa O, Yoshikawa T. Short-term high glucose exposure induces monocyte-endothelial cells adhesion and transmigration by increasing VCAM-1 and MCP-1 expression in human aortic endothelial cells. Atherosclerosis 2007;193:328-334.
22. Han KH, Chen Y, Chang MK, Han YC, Park JH, Green SR, Boullier A, Quehenberger O. LDL activates signaling pathways leading to an increase in cytosolic free calcium and stimulation of CD11b expression in monocytes. J Lipid Res 2003;44:1332-1340.
23. Abdi R, Means TK, Luster AD. Chemokines in islet allograft rejection. Diabetes Metab Res Rev 2003;19:186-190.
24. Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV Jr, Broxmeyer HE, Charo IF. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice. J Clin Invest 1997;100:2552-2561.
25. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 1998;187:601-608.
26. Gu L, Okada Y, Clinton SK, Gerard C, Sukhova GK, Libby P, Rollins BJ. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell 1998;2:275-281. (Pubitemid 128373654)
27. Van Riper G, Siciliano S, Fischer PA, Meurer R, Springer MS, Rosen H. Characterization and species distribution of high affinity GTP-coupled receptors for human rantes and monocyte chemoattractant protein 1. J Exp Med 1993;177:851-856. (Pubitemid 23104297)
28. Burns DL. Subunit structure and enzymic activity of pertussis toxin. Microbiol Sci 1988;5:285-287.